South Western Railway One Year After Nationalisation Progress and Reliability Questions Linger
Japans Landmark Intelligence Reform Implications for National Security and Defense Sector
DeepSeek AI Model Triggers SafeHaven Flows Yen and Swiss Franc Strengthen Against Dollar
Indias Gen Z Protests and Website Shutdown Highlight Rising Political Risk for Investors
US Productivity Growth Eases in Q4 While Unit Labor Costs Accelerate
SP 500 Mildly Higher as Healthcare and Tech Lead Communication Services Drag
MGRC Q1 2026 Earnings EPS Falls Short of Estimates Shares Inch Higher
UNF Q1 2026 Earnings Earnings Beat Expectations as EPS Surpasses Estimates
PEG Q1 2026 Earnings Earnings Beat Estimates Despite Slight Stock Decline
JOE Q1 2026 Earnings EPS of 024 Reported Stock Sees Slight Decline
CeriBell Inc CBLL Q1 2026 Earnings EPS Misses Estimates by 307 Stock Edges Higher
ADBE Q1 2026 Earnings EPS Tops Estimates Modestly
Dogness DOGZ Rebounds Approaching Key Resistance After 294 Gain
RWAYL Shows Minimal Movement as FixedIncome Investors Focus on Yield Stability
CarPartscom PRTS Holds Steady Near Support Levels as Modest Uptick Signals Caution
CleanSpark CLSK Shows Strength as Shares Climb 276 to 1620 Amid Broader Crypto Momentum
InflaRx NV IFRX Tumbles 684 as Shares Test Key Support at 226
Ryanair Posts Record Annual Profit of 226 Billion Amid Boeing Delivery Delays and Fuel Market Uncertainty
GILT Q1 2026 Earnings Massive EPS Surprise of 341 Despite Negative Market Reaction
SEBI Proposes Overhaul of IPO Price Discovery Mechanism Amid Distortion Concerns
Trinity Capital Inc 7875 Notes due 2029 TRINZ Q1 2026 Earnings Modest EPS Beat Meets Subdued Market Reaction
SpaceX Delays Starship V3 Test Flight Rescheduled for Friday Amid MultiBillion Dollar Development
China Prepares Humanoid Robots for Employment as Part of Industrial Strategy
TikTok and YouTube Face Scrutiny Over Child Safety Standards by UK Regulator Ofcom
Black Diamond Therapeutics BDTX Q1 2026 Earnings EPS Beat Fails to Lift Stock as Pipeline Uncertainty Lingers
CytoMed Therapeutics GDTC Drops 738 Key Support Levels in Focus Amid Selling Pressure